Investigation of the effects of urea cycle amino acids on the expression of ALB and CEBPB in the human hepatocellular carcinoma cell line FLC-4.
Amino Acids
/ pharmacology
Arginine
/ pharmacology
CCAAT-Enhancer-Binding Protein-beta
/ genetics
Carcinoma, Hepatocellular
/ genetics
Cell Line, Tumor
Culture Media
Gene Expression
/ drug effects
Hepatocytes
/ metabolism
Humans
Liver Neoplasms
/ genetics
Ornithine
/ pharmacology
RNA, Messenger
/ metabolism
Serum Albumin, Human
/ genetics
Albumin
Amino acid metabolism
Arginine
C/EBPβ
Nutrition
Ornithine
Journal
Human cell
ISSN: 1749-0774
Titre abrégé: Hum Cell
Pays: Japan
ID NLM: 8912329
Informations de publication
Date de publication:
Jul 2020
Jul 2020
Historique:
received:
23
04
2020
accepted:
24
05
2020
pubmed:
1
6
2020
medline:
4
9
2020
entrez:
1
6
2020
Statut:
ppublish
Résumé
Cell lines are powerful tools for research into liver function at the molecular level. However, they are generally unsuitable for rigorously assessing the effects of amino acid composition, because many lines require serum-containing medium for their maintenance. Here, we aimed to investigate the effects of ornithine and arginine, which are included in the characteristic metabolic process in hepatocyte, on a human hepatoma-derived cell line (FLC-4) that can be cultured in serum-free medium. FLC-4 cells were cultured under the following three conditions: + ornithine/ - arginine, - ornithine/ - arginine, and -ornithine/ + arginine. Albumin expression evaluated by quantitative polymerase chain reaction and enzyme-linked immunosorbent assay and showed no obvious differences based on the presence of ornithine or arginine. However, the mRNA levels of two liver-enriched transcription factors (CEBPB and HNF1A), which are involved in regulating albumin expression, were significantly higher in cells grown in medium-containing arginine than that in cells grown in ornithine-containing medium. Western blotting showed that the levels both activating and inhibitory C/EBPβ isoforms were significantly increased in cells grown in arginine medium. Furthermore, we have found that depletion of both ornithine and arginine, the polyamine sources, in the medium did not cause polyamine deficiency. When ornithine and arginine were depleted, albumin production was significantly reduced at the mRNA level, CEBPB mRNA levels were increased, and the level of activating form of C/EBPβ was increased. The results of this study suggest that in hepatocyte, these two amino acids might have different functions, and because of which they elicit disparate cellular responses.
Identifiants
pubmed: 32474770
doi: 10.1007/s13577-020-00383-1
pii: 10.1007/s13577-020-00383-1
pmc: PMC7324429
doi:
Substances chimiques
ALB protein, human
0
Amino Acids
0
CCAAT-Enhancer-Binding Protein-beta
0
CEBPB protein, human
0
Culture Media
0
RNA, Messenger
0
Arginine
94ZLA3W45F
Ornithine
E524N2IXA3
Serum Albumin, Human
ZIF514RVZR
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
590-598Subventions
Organisme : Japan Agency for Medical Research and Development
ID : JP19fk0310112h0003
Organisme : Japan Agency for Medical Research and Development
ID : JP20fk0310112h0004
Références
Fujise K, Nagamori S, Hasumura S, et al. Integration of hepatitis B virus DNA into cells of six established human hepatocellular carcinoma cell lines. Hepatogastroenterology. 1990;37:457–60.
pubmed: 1701409
Saito M, Matsuura T, Masaki T, et al. Reconstruction of liver organoid using a bioreactor. World J Gastroenterol. 2006;12:1881–8.
doi: 10.3748/wjg.v12.i12.1881
Kanai H, Marushima H, Kimura N, et al. Extracorporeal bioartificial liver using the radial-flow bioreactor in treatment of fatal experimental hepatic encephalopathy. Artif Organs. 2007;31:148–51.
doi: 10.1111/j.1525-1594.2007.00354.x
Matsumoto M, Matsuura T, Aoki K, et al. An efficient system for secretory production of fibrinogen using a hepatocellular carcinoma cell line. Hepatol Res. 2015;45:315–25.
doi: 10.1111/hepr.12353
Tomizawa M, Shinozaki F, Motoyoshi Y, Sugiyama T, Yamamoto S, Ishige N. Hepatocyte selection medium eliminating induced pluripotent stem cells among primary human hepatocytes. World J Methodol. 2015;5:108–14.
doi: 10.5662/wjm.v5.i3.108
West BJ, ed. Best and Taylor's physiological basis of medical practice. Baltimore: Williams & Wilkins 1991.
Oratz M, Rothschild MA, Schreiber SS, Burks A, Mongelli J, Matarese B. The role of the urea cycle and polyamines in albumin synthesis. Hepatology. 1983;3:567–71.
doi: 10.1002/hep.1840030415
Sani BP, Meeks RG. Subacute toxicity of all-trans- and 13-cis-isomers of N-ethyl retinamide, N-2-hydroxyethyl retinamide, and N-4-hydroxyphenyl retinamide. Toxicol Appl Pharmacol. 1983;70:228–35.
doi: 10.1016/0041-008X(83)90098-4
Woodworth CD, Isom HC. Regulation of albumin gene expression in a series of rat hepatocyte cell lines immortalized by simian virus 40 and maintained in chemically defined medium. Mol Cell Biol. 1987;7:3740–8.
doi: 10.1128/MCB.7.10.3740
Yamada Y, Shidoji Y, Fukutomi Y, et al. Positive and negative regulations of albumin gene expression by retinoids in human hepatoma cell lines. Mol Carcinog. 1994;10:151–8.
doi: 10.1002/mc.2940100306
Kimball SR, Horetsky RL, Jefferson LS. Hormonal regulation of albumin gene expression in primary cultures of rat hepatocytes. Am J Physiol. 1995;268:E6–14.
pubmed: 7840183
Herlong HF, Jr. MCM, eds. Laboratory tests. 11th edn. UK: Wiley-Blackwell; 2012.
Carmichael E, Wu YG, editors. Transcription, RNA processing, liver specific factors, RNA translocation, translation, protein cotranslocation, secretion. 2nd ed. Oxford: Oxford University Press; 1999.
Wu G. Amino acids. London: CRC Press Taylor & Francis Group; 2013.
Coleman CS, Hu G, Pegg AE. Putrescine biosynthesis in mammalian tissues. Biochem J. 2004;379:849–55.
doi: 10.1042/bj20040035
Lescoat G, Theze N, Fraslin JM, Pasdeloup N, Kneip B, Guguen-Guillouzo C. Influence of ornithine on albumin synthesis by fetal and neonatal hepatocytes maintained in culture. Cell Differ. 1987;21:21–9.
doi: 10.1016/0045-6039(87)90444-1
Lescoat G, Desvergne B, Loreal O, et al. Modulation of albumin secretion by ornithine alpha-ketoglutarate in adult rat hepatocyte cultures and a human hepatoma cell line (HepG2). Ann Nutr Metab. 1989;33:252–60.
doi: 10.1159/000177542
Aizaki H, Nagamori S, Matsuda M, et al. Production and release of infectious hepatitis C virus from human liver cell cultures in the three-dimensional radial-flow bioreactor. Virology. 2003;314:16–25.
doi: 10.1016/S0042-6822(03)00383-0
Kosuge M, Takizawa H, Maehashi H, Matsuura T, Matsufuji S. A comprehensive gene expression analysis of human hepatocellular carcinoma cell lines as components of a bioartificial liver using a radial flow bioreactor. Liver Int. 2007;27:101–8.
doi: 10.1111/j.1478-3231.2006.01410.x
Kobayashi K, Yoshida A, Ejiri Y, et al. Increased expression of drug-metabolizing enzymes in human hepatocarcinoma FLC-4 cells cultured on micro-space cell culture plates. Drug Metab Pharmacokinet. 2012;27:478–85.
doi: 10.2133/dmpk.DMPK-12-RG-016
Onoue H, Matsufuji S, Nishiyama M, Murakami Y, Hayashi S. Changes in ornithine decarboxylase and antizyme activities in developing mouse brain. Biochem J. 1988;250:797–803.
doi: 10.1042/bj2500797
Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25:402–8.
doi: 10.1006/meth.2001.1262
Friedman AD, Landschulz WH, McKnight SL. CCAAT/enhancer binding protein activates the promoter of the serum albumin gene in cultured hepatoma cells. Genes Dev. 1989;3:1314–22.
doi: 10.1101/gad.3.9.1314
Tronche F, Rollier A, Bach I, Weiss MC, Yaniv M. The rat albumin promoter: cooperation with upstream elements is required when binding of APF/HNF1 to the proximal element is partially impaired by mutation or bacterial methylation. Mol Cell Biol. 1989;9:4759–66.
doi: 10.1128/MCB.9.11.4759
Johnson PF. Transcriptional activators in hepatocytes. Cell Growth Differ. 1990;1:47–52.
pubmed: 2078499
Buck M, Turler H, Chojkier M. LAP (NF-IL-6), a tissue-specific transcriptional activator, is an inhibitor of hepatoma cell proliferation. EMBO J. 1994;13:851–60.
doi: 10.1002/j.1460-2075.1994.tb06328.x
Buck M, Chojkier M. Signal transduction in the liver: C/EBPbeta modulates cell proliferation and survival. Hepatology. 2003;37:731–8.
doi: 10.1053/jhep.2003.50155
Descombes P, Schibler U. A liver-enriched transcriptional activator protein, LAP, and a transcriptional inhibitory protein, LIP, are translated from the same mRNA. Cell. 1991;67:569–79.
doi: 10.1016/0092-8674(91)90531-3
Kajiyama Y, Tian J, Locker J. Characterization of distant enhancers and promoters in the albumin-alpha-fetoprotein locus during active and silenced expression. J Biol Chem. 2006;281:30122–31.
doi: 10.1074/jbc.M603491200
Iacob R, Rudrich U, Rothe M, et al. Induction of a mature hepatocyte phenotype in adult liver derived progenitor cells by ectopic expression of transcription factors. Stem Cell Res. 2011;6:251–61.
doi: 10.1016/j.scr.2011.02.002
Hou Y, Yin Y, Wu G. Dietary essentiality of "nutritionally non-essential amino acids" for animals and humans. Exp Biol Med (Maywood). 2015;240:997–1007.
doi: 10.1177/1535370215587913
Pegg AE. Mammalian polyamine metabolism and function. IUBMB Life. 2009;61:880–94.
doi: 10.1002/iub.230
Coburn RF. Polyamine effects on cell function: possible central role of plasma membrane PI(4,5)P2. J Cell Physiol. 2009;221:544–51.
doi: 10.1002/jcp.21899
Morrison DM, Goldsmith LA. Ornithine decarboxylase in rat skin. J Invest Dermatol. 1978;70:309–13.
doi: 10.1111/1523-1747.ep12543474